Detalles de la búsqueda
1.
Are you vaccinated? COVID-19 vaccination rates and the effect of a vaccination program in a metropolitan mental health inpatient population in Australia.
Australas Psychiatry;
31(1): 38-42, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36337038
2.
Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer.
Invest New Drugs;
39(5): 1399-1404, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33835357
3.
Predictive factors of survival in patients with borderline resectable pancreatic cancer who received neoadjuvant therapy.
Pancreatology;
21(8): 1451-1459, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34462214
4.
Randomized phase II study of chemoradiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group trial, JCOG1106.
Jpn J Clin Oncol;
51(2): 235-243, 2021 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33164066
5.
Human equilibrative nucleoside transporter-1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S-1 chemotherapy.
Cancer Sci;
111(2): 548-560, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31778273
6.
FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer: A subset analysis of data from a nationwide multicenter observational study in Japan.
Pancreatology;
20(7): 1519-1525, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32972834
7.
Prognostic impact of abutment to the branches of the superior mesenteric artery in borderline resectable pancreatic cancer.
Langenbecks Arch Surg;
405(7): 939-947, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32852631
8.
Impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX.
Cancer Sci;
110(2): 707-716, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30447099
9.
FOLFIRINOX for locally advanced pancreatic cancer: Results and prognostic factors of subset analysis from a nation-wide multicenter observational study in Japan.
Pancreatology;
19(2): 296-301, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30638853
10.
Comparison of enteral nutrition with total parenteral nutrition for patients with locally advanced unresectable esophageal cancer harboring dysphagia in definitive chemoradiotherapy.
Jpn J Clin Oncol;
49(10): 910-918, 2019 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31219161
11.
Pharmacokinetics of S-1 monotherapy in plasma and in tears for gastric cancer patients.
Int J Clin Oncol;
24(6): 660-665, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31011915
12.
Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine.
Cancer Sci;
109(1): 215-224, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29121415
13.
Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.
BMC Cancer;
18(1): 573, 2018 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29776344
14.
Protocol digest of randomized phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel combination therapy for locally advanced pancreatic cancer: Japan clinical oncology group study (JCOG1407).
Pancreatology;
18(7): 841-845, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30075908
15.
Role of hepatectomy in gastric cancer with multiple liver-limited metastases.
Gastric Cancer;
21(2): 338-344, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28577228
16.
Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy.
Int J Clin Oncol;
23(6): 1189-1195, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29948238
17.
Phase II study of S-1 plus oxaliplatin 130 mg/m2 in Japanese patients with advanced gastric cancer.
Int J Clin Oncol;
23(6): 1084-1089, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29931597
18.
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Lancet;
388(10041): 248-57, 2016 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-27265347
19.
Phase II study of lanreotide autogel in Japanese patients with unresectable or metastatic well-differentiated neuroendocrine tumors.
Invest New Drugs;
35(4): 499-508, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28470558
20.
Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer.
Oncology;
93(5): 329-335, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28866662